Hiroshi Haneda et al.
Japanese journal of clinical oncology, 36(2), 69-75 (2006-02-02)
The presence of epidermal growth factor receptor (EGFR) mutations in gefitinib-naive lung cancer patients has been reported to be higher in females, in non-smokers, in Japanese, and in adenocarcinoma patients, especially in bronchioloalveolar carcinoma (BAC). To further investigate the prevalence